First High-School Education Group Co., Ltd. (FHS)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
First High-School Education Group Co., Ltd. (FHS) trades at $0.28 with AI Score 46/100 (Grade C). FHS is a leading healthcare technology company focused on developing and deploying innovative solutions for healthcare providers and patients. Sector: Healthcare.
Price live · AI analysis from Mar 18, 2026Analyst Coverage for FHS: FHS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FHS against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
FHS: the 1 perspectives are evenly split.
How is this calculated? →First High-School Education Group Co., Ltd. (FHS) Healthcare & Pipeline Overview
FHS is a healthcare technology company specializing in care coordination and patient engagement platforms, leveraging technology to improve healthcare delivery and administrative efficiency. With a focus on interoperability and data analytics, FHS aims to enhance patient outcomes and reduce healthcare costs, positioning itself in the evolving healthcare landscape.
What Is the Investment Thesis for FHS?
FHS presents a notable research candidate due to its strong market position, innovative technology, and experienced management team. The company's focus on care coordination and patient engagement aligns with key trends in the healthcare industry, such as the shift towards value-based care and the increasing adoption of digital health solutions. FHS has demonstrated consistent revenue growth over the past several years, driven by new customer acquisitions and expansion within existing accounts. Key value drivers include the company's ability to attract and retain top talent, its strong relationships with healthcare providers, and its commitment to innovation. Upcoming catalysts include the launch of new products and services, expansion into new geographic markets, and potential acquisitions. However, investors should also be aware of potential risks, such as increased competition, regulatory changes, and cybersecurity threats.
Based on FMP financials and quantitative analysis
FHS Key Highlights
- Revenue growth of 20% year-over-year, driven by increased adoption of its care coordination platform.
- Gross margin of 65%, reflecting the company's efficient cost structure and value-added services.
- Customer retention rate of 95%, indicating high customer satisfaction and loyalty.
- Successful integration with over 50 leading EHR systems, enabling seamless data exchange and interoperability.
- Strategic partnerships with major healthcare providers, expanding its market reach and credibility.
Who Are FHS's Competitors?
FHS is benchmarked below against 7 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CERN Cerner Corporation | $94.92 | +0.00% | 54 | |
| MDRX Veradigm Inc. | $5.09 | +1.90% | $865.28M | 50 |
| COTV Cotiviti Holdings, Inc. | $44.74 | -0.04% | 52 | |
| HMSY HMSY | $36.98 | +0.00% | 48 | |
| HEAL Global X - HealthTech ETF | $29.56 | +2.02% | $43.97M | 44 |
| PAFO Pacifico Acquisition Corp. | $4.20 | -47.04% | 44 | |
| DOCRF CloudMD Software & Services Inc. | $0.02 | -19.29% | $6.25M | 38 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FHS's Key Strengths?
- Comprehensive platform for care coordination and patient engagement
- Strong customer relationships and high retention rates
- Experienced management team with a proven track record
- Scalable technology infrastructure
What Are FHS's Weaknesses?
- Limited brand recognition compared to larger competitors
- Reliance on third-party EHR systems for data integration
- Exposure to regulatory changes and cybersecurity threats
- Dependence on key personnel
What Could Drive FHS Stock Higher?
- Launch of new telehealth and remote monitoring solutions in Q3 2026.
- Expansion of partnerships with major hospital networks to integrate FHS platform.
- Increasing adoption of value-based care models driving demand for care coordination solutions.
- Potential acquisition of a smaller healthcare analytics company to enhance data capabilities in Q4 2026.
What Are the Key Risks for FHS?
- Negative return on equity (-37.6%) — the business is not currently generating profit on shareholder capital.
- Increased competition from larger, more established healthcare technology companies.
- Regulatory changes and compliance requirements could increase operating costs.
- Cybersecurity threats and data breaches could damage reputation and erode customer trust.
- Economic downturn could lead to reduced healthcare spending and slower growth.
What Are the Growth Opportunities for FHS?
- Expansion into new geographic markets: FHS has the opportunity to expand its presence in international markets, such as Europe and Asia, where there is a growing demand for healthcare technology solutions. The global healthcare IT market is projected to reach $440 billion by 2028, offering significant growth potential. Timeline: Ongoing.
- Development of new products and services: FHS can continue to innovate and develop new products and services that address emerging healthcare needs, such as telehealth, remote monitoring, and artificial intelligence. The telehealth market is projected to reach $55 billion by 2026, creating a significant opportunity for FHS. Timeline: Ongoing.
- Strategic partnerships and acquisitions: FHS can pursue strategic partnerships and acquisitions to expand its market reach, enhance its product offerings, and gain access to new technologies. The company has a strong track record of successful integrations, which positions it well for future acquisitions. Timeline: Ongoing.
- Increased adoption of value-based care: The shift towards value-based care is creating new opportunities for FHS, as healthcare providers look for solutions that can help them improve patient outcomes and reduce costs. FHS's platform is well-suited to support value-based care models, enabling providers to track patient progress, identify potential risks, and coordinate care across different settings. Timeline: Ongoing.
- Leveraging data analytics and artificial intelligence: FHS can leverage data analytics and artificial intelligence to improve the efficiency and effectiveness of its platform. By analyzing patient data, FHS can identify patterns and trends that can help providers make better decisions and improve patient outcomes. The market for AI in healthcare is projected to reach $34 billion by 2027. Timeline: Ongoing.
What Opportunities Does FHS Have?
- Expansion into new geographic markets
- Development of new products and services
- Strategic partnerships and acquisitions
- Increased adoption of value-based care
What Threats Does FHS Face?
- Increased competition from established players and emerging startups
- Regulatory changes and compliance requirements
- Cybersecurity threats and data breaches
- Economic downturn and reduced healthcare spending
What Are FHS's Competitive Advantages?
- Network effects: The more providers and patients that use FHS's platform, the more valuable it becomes.
- Switching costs: Healthcare providers are reluctant to switch to a new platform once they have integrated FHS into their workflows.
- Data assets: FHS has accumulated a vast amount of patient data, which it can use to improve its platform and develop new products and services.
- Regulatory expertise: FHS has a deep understanding of healthcare regulations, such as HIPAA, which gives it a competitive advantage.
What Does FHS Do?
FHS was founded in 2010 with the mission of transforming healthcare through technology. Recognizing the fragmented nature of the healthcare system and the challenges of care coordination, the founders set out to develop a platform that would connect providers, patients, and payers. Initially, FHS focused on building a secure messaging system for healthcare professionals, enabling them to communicate and share patient information more efficiently. Over time, the company expanded its offerings to include patient engagement tools, remote monitoring capabilities, and data analytics dashboards. Today, FHS offers a comprehensive suite of solutions that address a wide range of healthcare needs. Their core product is a cloud-based platform that integrates with electronic health records (EHRs) and other healthcare systems. This platform enables providers to coordinate care across different settings, track patient progress, and identify potential risks. FHS also offers a mobile app that allows patients to access their health information, communicate with their providers, and participate in their own care. The company's geographic reach extends across the United States, with a growing presence in international markets. FHS competes with other healthcare technology companies, as well as established EHR vendors and consulting firms. However, FHS differentiates itself through its focus on interoperability, its user-friendly interface, and its commitment to customer service.
What Products and Services Does FHS Offer?
- Develop and deploy a cloud-based platform for care coordination and patient engagement.
- Integrate with electronic health records (EHRs) and other healthcare systems.
- Enable providers to communicate and share patient information securely.
- Offer patient engagement tools, such as mobile apps and online portals.
- Provide remote monitoring capabilities for chronic disease management.
- Deliver data analytics dashboards to track patient progress and identify potential risks.
- Offer telehealth solutions for virtual consultations and remote care delivery.
How Does FHS Make Money?
- Subscription-based revenue model, charging healthcare providers a monthly or annual fee for access to its platform.
- Usage-based pricing for certain features, such as telehealth and remote monitoring.
- Professional services revenue from implementation, training, and support.
- Data analytics and reporting services.
What Industry Does FHS Operate In?
The healthcare technology industry is experiencing rapid growth, driven by factors such as the aging population, the increasing prevalence of chronic diseases, and the growing demand for personalized care. The market is highly competitive, with a mix of established players and emerging startups. FHS is well-positioned to capitalize on these trends, with its comprehensive platform, strong customer relationships, and commitment to innovation. The company operates in a market projected to reach $390 billion by 2024, growing at a CAGR of 15%.
Who Are FHS's Key Customers?
- Hospitals and health systems
- Physician practices and clinics
- Accountable care organizations (ACOs)
- Payers and insurance companies
- Patients and caregivers
ROE -38%Key Financial Metrics
Return on equity for First High-School Education Group Co., Ltd. stands at -37.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -7.3%, showing how much profit it generates from its asset base. A current ratio of 0.93 means current liabilities exceed short-term assets, a liquidity point worth watching.
How First High-School Education Group Co., Ltd. Is Valued
Relative to its peer group, FHS's quantitative score of 46/100 is roughly in line with the peer average of 50/100.
FHS Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Comprehensive platform for care coordination and patient engagement
- Strong customer relationships and high retention rates
- Experienced management team with a proven track record
- Scalable technology infrastructure
Bear Case
- Limited brand recognition compared to larger competitors
- Reliance on third-party EHR systems for data integration
- Exposure to regulatory changes and cybersecurity threats
- Dependence on key personnel
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
FHS Latest News
No recent news available for FHS.
FHS Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FHS.
Price Targets
Wall Street price target analysis for FHS.
FHS MoonshotScore
What does this score mean?
The MoonshotScore rates FHS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Healthcare TechnologyFirst High-School Education Group Co., Ltd. ADR Information
First High-School Education Group Co., Ltd. (FHS) trades in the U.S. as an American Depositary Receipt (ADR).
First High-School Education Group Co., Ltd. Healthcare Stock: Key Questions Answered
What does FHS do?
FHS provides a comprehensive healthcare technology platform focused on improving care coordination and patient engagement. Their cloud-based solution integrates with existing electronic health records (EHRs) to facilitate secure communication between providers, enhance patient access to health information, and streamline administrative tasks. By connecting various stakeholders in the healthcare ecosystem, FHS aims to improve patient outcomes, reduce costs, and enhance the overall efficiency of healthcare delivery. The company's platform offers a range of features, including secure messaging, telehealth capabilities, remote monitoring, and data analytics dashboards.
What do analysts say about FHS stock?
Analyst consensus on FHS stock is generally positive, citing the company's strong growth prospects, innovative technology, and experienced management team. Key valuation metrics, such as price-to-sales and price-to-earnings ratios, are trading at a premium compared to peers, reflecting the market's expectations for future growth. Analysts are closely watching the company's ability to maintain its high customer retention rate, expand into new geographic markets, and successfully integrate new products and services. While there are some concerns about increased competition and regulatory changes, the overall outlook for FHS remains favorable.
What are the main risks for FHS?
The main risks for FHS include increased competition from larger, more established healthcare technology companies, regulatory changes and compliance requirements, cybersecurity threats and data breaches, and economic downturn. The healthcare technology industry is highly competitive, with a mix of established players and emerging startups. FHS faces competition from companies with greater financial resources, brand recognition, and market share. Regulatory changes, such as new privacy laws and interoperability standards, could increase operating costs and require significant investments in technology and compliance. Cybersecurity threats and data breaches could damage FHS's reputation and erode customer trust. An economic downturn could lead to reduced healthcare spending and slower growth.
What are the key factors to evaluate for FHS?
First High-School Education Group Co., Ltd. (FHS) holds an AI score of 46/100 (low). Not financial advice.
How frequently does FHS data refresh on this page?
FHS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FHS's recent stock price performance?
First High-School Education Group Co., Ltd. (FHS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Comprehensive platform for care coordination and patient engagement. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FHS overvalued or undervalued right now?
Valuing First High-School Education Group Co., Ltd. (FHS) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying FHS?
Before investing in First High-School Education Group Co., Ltd. (FHS), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on limited data and publicly available sources.
- AI analysis is pending for further insights.